Literature DB >> 18498441

Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.

Sabrina Jabs1, Arne Quitsch, Reijo Käkelä, Bettina Koch, Jaana Tyynelä, Helmut Brade, Markus Glatzel, Steven Walkley, Paul Saftig, Marie T Vanier, Thomas Braulke.   

Abstract

The neuronal ceroid lipofuscinoses comprise a group of inherited severe neurodegenerative lysosomal disorders characterized by lysosomal dysfunction and massive accumulation of fluorescent lipopigments and aggregated proteins. To examine the role of lipids in neurodegenerative processes of these diseases, we analysed phospho- and glycolipids in the brains of ctsd-/- and nclf mice, disease models of cathepsin D and CLN6 deficiency, respectively. Both ctsd-/- and nclf mice exhibited increased levels of GM2 and GM3 gangliosides. Immunohistochemically GM2 and GM3 staining was found preferentially in neurons and glial cells, respectively, of ctsd-/- mice. Of particular note, a 20-fold elevation of the unusual lysophospholipid bis(monoacylglycero)phosphate was specifically detected in the brain of ctsd-/- mice accompanied with sporadic accumulation of unesterified cholesterol in distinct cells. The impaired processing of the sphingolipid activator protein precursor, an in vitro cathepsin D substrate, in the brain of ctsd-/- mice may provide the mechanistic link to the storage of lipids. These studies show for the first time that cathepsin D regulates the lysosomal phospho- and glycosphingolipid metabolism suggesting that defects in the composition, trafficking and/or recycling of membrane components along the late endocytic pathway may be critical for the pathogenesis of early onset neuronal ceroid lipofuscinoses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498441     DOI: 10.1111/j.1471-4159.2008.05497.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Mitsuo Saito; Asok Kumar; Jose A Rodriguez-Navarro; Monika Pawlik; Chunfeng Huo; Steven U Walkley; Mariko Saito; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2014-09-29       Impact factor: 13.501

2.  α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2.

Authors:  Lauren R Kett; Barbara Stiller; Megan M Bernath; Inmaculada Tasset; Javier Blesa; Vernice Jackson-Lewis; Robin B Chan; Bowen Zhou; Gilbert Di Paolo; Serge Przedborski; Ana Maria Cuervo; William T Dauer
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

Review 3.  Multi-system disorders of glycosphingolipid and ganglioside metabolism.

Authors:  You-Hai Xu; Sonya Barnes; Ying Sun; Gregory A Grabowski
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

4.  Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking.

Authors:  Carolin Schmidtke; Stephan Tiede; Melanie Thelen; Reijo Käkelä; Sabrina Jabs; Georgia Makrypidi; Marc Sylvester; Michaela Schweizer; Ingke Braren; Nahal Brocke-Ahmadinejad; Susan L Cotman; Angela Schulz; Volkmar Gieselmann; Thomas Braulke
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

5.  Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.

Authors:  Zeynep Akgoc; Miguel Sena-Esteves; Douglas R Martin; Xianlin Han; Alessandra d'Azzo; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2015-03-20       Impact factor: 5.922

6.  Lysosomal dysfunction causes neurodegeneration in mucolipidosis II 'knock-in' mice.

Authors:  K Kollmann; M Damme; S Markmann; W Morelle; M Schweizer; I Hermans-Borgmeyer; A K Röchert; S Pohl; T Lübke; J-C Michalski; R Käkelä; S U Walkley; T Braulke
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

Review 7.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

8.  Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV.

Authors:  Matthew C Micsenyi; Kostantin Dobrenis; Gloria Stephney; James Pickel; Marie T Vanier; Susan A Slaugenhaupt; Steven U Walkley
Journal:  J Neuropathol Exp Neurol       Date:  2009-02       Impact factor: 3.685

9.  Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo.

Authors:  Valerie Cullen; Maria Lindfors; Juliana Ng; Anders Paetau; Erika Swinton; Piotr Kolodziej; Heather Boston; Paul Saftig; John Woulfe; Mel B Feany; Liisa Myllykangas; Michael G Schlossmacher; Jaana Tyynelä
Journal:  Mol Brain       Date:  2009-02-09       Impact factor: 4.041

10.  Alterations in endo-lysosomal function induce similar hepatic lipid profiles in rodent models of drug-induced phospholipidosis and Sandhoff disease.

Authors:  Emmanuelle Lecommandeur; David Baker; Timothy M Cox; Andrew W Nicholls; Julian L Griffin
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.